Specificity: OR1L8 Antibody detects endogenous levels of total OR1L8.
Host: Rabbit
Application: WB
Species Reactivity: Human
Summary
Specifications
Antibody Isotype
IgG
Species Reactivity
Human
Immunogen
A synthesized peptide derived from human OR1L8, corresponding to a region within C-terminal amino acids.
Conjugate
Unconjugated
Applications
Application Notes
WB 1:1000-3000
General Notes
This product (Catalog No. CABT-BL2797) is a rabbit-derived polyclonal antibody raised against human OR1L8. It has been affinity purified by Protein A. Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. CABT-BL2797 is suitable for use in WB 1 (1000-3000) application. CABT-BL2797 is supplied as a liquid formulation in Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human OR1L8 (C-terminal) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.